HF
NVAX icon

HRT Financial’s Novavax NVAX Stock Holding History

HRT Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$816K Sell
100,300
-900
-0.9% -$8.16K ﹤0.01% 2181
2025
Q4 		$680K Buy
+101,200
New +$763K ﹤0.01% 1942
2022
Q2 		– Sell
-3,700
Closed -$272K – 3470
2022
Q1 		$272K Buy
+3,700
New +$330K ﹤0.01% 2302
2021
Q4 		– Sell
-13,800
Closed -$2.86M – 3789
2021
Q3 		$2.86M Buy
13,800
+10,600
+331% +$2.34M 0.02% 529
2021
Q2 		$679K Sell
3,200
-24,300
-88% -$4.45M 0.01% 1508
2021
Q1 		$4.99M Buy
27,500
+24,200
+733% +$4.82M 0.05% 294
2020
Q4 		$367K Sell
3,300
-6,200
-65% -$659K 0.01% 1180
2020
Q3 		$1.03M Buy
+9,500
New +$1.16M 0.03% 519

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's NVAX Position: Q1 2026 in Review

HRT Financial sold out of Novavax (NVAX) in Q1 2026, closing a stake of 834,223 shares — an estimated $7.56M sold.

HRT Financial first reported a position in NVAX in Q2 2015 and held it in 16 quarters. The position peaked at $23.2M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • HRT Financial reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 834,223 Novavax shares in Q1 2026, an estimated $7.56M.
  • HRT Financial first reported a position in Novavax in Q2 2015 and held it in 16 quarters.
  • HRT Financial's Novavax position peaked at $23.2M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.